Medications for Fallopian Tube Neoplasms
3 results
Elahere (mirvetuximab soravtansine)
(MIRVETUXIMAB SORAVTANSINE)ImmunoGen, Inc.
Usage: ELAHERE® is indicated for adult patients with folate receptor-alpha positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, after one to three prior systemic treatments. Patient selection should be based on an FDA-approved test.
Zejula (niraparib)
(niraparib)GlaxoSmithKline LLC
Usage: ZEJULA is indicated for the maintenance treatment of adult patients with advanced ovarian, fallopian tube, or primary peritoneal cancer responding to first-line platinum-based chemotherapy, as well as for those with recurrent germline BRCA-mutated cancer in response to such chemotherapy.
Zirabev (bevacizumab-bvzr)
(bevacizumab-bvzr)Pfizer Laboratories Div Pfizer Inc
Usage: ZIRABEV is indicated for the treatment of metastatic colorectal cancer, first-line non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, persistent or recurrent cervical cancer, and advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer, often in combination with other agents.